Abstract:Objective The incidence of acute pulmonary injury occurred after cardiopulmonary bypass for fallot tetrad has been high. The severity of pulmonary ischemia-reperfusion has been found to be reduced with ulinastatin (UTI) in the animal models and clinical practice. We evaluated the effect of pulmonary artery perfusion with a hypothermic protective solution containing ulinastatin on the inflammatory response in the lung during cardiopulmonary bypass. Methods 30 children with tetralogy of Fallot (TOF) were randomly assigned into control group and protective group, 15 cases in each group. Patients would be excluded if they had signs of infections, such as the white blood cell count was over 12000 per microliter, the temperature was above 38 centi-degree and the c-reaction protein was more than 8 mg/L. Operation with routine approaches was performed in the control group and the pulmonary artery was infused with 4℃ protective solution in the protective group while the heart stoped beating. Plasma tumor necrosis factor α (TNF-α) 、CD11b and Myeloperoxidase (MPO) were measured intraoperatively and postoperatively. Blood gas、pulmonary function and clinic index of the patients were also monitored. Results The level of TNF-α was lower in the protective group as compared with that in the control group immediately and 3 hours after closing the sternum [(11.15±2.47) pg/ml vs. (14.21 ±5.55) pg/ml, P<0.05; (12.01 ±2.69) pg/ml vs. (15.94 ±4.86)pg/ml,P <0.01]. The MFI of CD11b was lower in the protective group as compared with that in the control group at 3 and 6 hoursafter closing the sternum (126.23±36.05 vs. 156.98±48.34, P<0.05; 137.27±38.85 vs. 173.27±67.43, P<0.05). The level of MPO was lower in protective group as compared with that in the control group at 3 hours, 6 hours and 24hours after closing the sternum [(156.52±17.57)U/L vs.(178.45±35.68)U/L, P<0.05; (178.28±23.63) U/L vs.(224.66±49.66)U/L, P<0.01;(130.52±57.50)U/L vs. (96.50±14.49)U/L, P<0.05]. The duration of mechanical ventilation was significantly shorter in the protective group than that in the control group (17.60±6.39 vs. 23.70±8.51,P<0.05). Alveolar-arterial oxygen pressure difference (A-aDO2, calculated as [FiO2×713-5/4×PaCO2]-PaO2) in the protective group was less than that in the control group at 3 and 6 hours after closing the sternum [(120.92±33.08)mm Hg vs. (145.52±39.38)mmHg, P<0.05;(74.76±40.16)mm Hg vs. (112.50±44.16)mmHg, P<0.01]. Dynamic compliance (Cdyn) in protective group was lower than that in control group at 3 and 6 hours after closing the sternum [(0.59±0.11)ml·cmH2O-1·kg-1 vs. (0.46±0.17)ml·cmH2O-1·kg-1, P<0.05;(0.67±0.09)ml·cmH2O-1·kg-1vs. (0.53±0.18)ml·cmH2O-1·kg-1,P<0.05). Conclusion Perfusion with hypothermic protective solution containing UTI to the pulmonary artery during cardiopulmonary bypass may reduce the inflammatory responses substantially in the lung after bypass and had a role in the lung protection.

Protective effect of hyperoxia liquid preconditioning on myocardium during coronary artery bypass graft

Myocardium protective effects of repeated hyperbaric oxygen preconditioning in patients undergoing coronary artery bypass graft surgery

Preconditioning with repeated hyperbaric oxygen induces myocardial and cerebral protection in patients undergoing coronary artery bypass graft surgery: a prospective, randomized, controlled clinical trial.

The protective role of hypothermic protective solution during surgey for the tetralogy of Fallot

Protective effect of hyperoxia liquid on myocardial ischemia reperfusion

Influence of Ischemic Preconditioning on Cardiac Release of NO and Vascular Endothelial Function During Cardiopulmonary Bypass

Preconditioning Effects of Butorphanol in Patients Undergoing on-pump Coronary Artery Bypass Graft Surgery

Isoflurane Preconditioning-Induced Cardio-Protection in Patients Undergoing Coronary Artery Bypass Grafting.

Experimental study on protection effect of lungischemic preconditioning for lung and myocardiuin canine cardio pulmonary bypass

Protective Effect of Pulmonary Artery Perfusion with Hypothermic Solution during Cardiopulmonary Bypass on Lung Function

Management of Cardiopulmonary Bypass Proceduce During Coronary Artery Bypass Graft Surgery

Effects of arterial oxygen partial pressures during cardiopulmonary bypass on myocardial antioxidant capacity in cyanotic heart diseases

Impact of lung ischemic preconditioning on myocardium in canine cardiopulmonary bypass

Effects of Remote Ischemic Preconditioning in Patients Undergoing Off-Pump Coronary Artery Bypass Graft Surgery

Effect of high concentration carbon dioxide preconditioning on lipid peroxidation daring myocardial ischemia-reperfusion in rabbits

Effects of hyperoxia liquid on apoptosis by ischemia/reperfusion injury in rat

Protective Effects of Hypovolemic Hypotension Preconditioning on Cardiopulmonary Function after Myocardium Ischemia/reperfusion Injury.

Anti-apoptotic Effect of Hyperbaric Oxygen Preconditioning on a Rat Model of Myocardial Infarction.

Effects of Hyperbaric Oxygen Preconditioning on Post Operative Cognitive Dysfunction and Expression Levels of Mir-146A and Mir-572 in Patients with Coronary Artery Bypass Grafting

Myocardial protection of warm blood cardioplegia induction and reperfusion during cardiopulmonary bypass

Beneficial Effects of Hyperosmotic Perfusion in the Myocardium after Ischemia/reperfusion Injury in Isolated Rat Hearts.